Browsing by Author Melero, I. (Ignacio)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 109 to 128 of 168 < previous   next >
Issue DateTitleTypeAuthor(s)
2006Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinomaArticuloTirapu, I. (Íñigo); Huarte, E. (Eduardo); Guiducci, C. (Cristiana); Arina, A. (Ainhoa); Zaratiegui, M. (Mikel); Murillo, O. (Oihana); Gonzalez-Hernandez, A. (Alvaro); Berasain, C. (Carmen); Berraondo, P. (Pedro); Fortes, P. (Puri); Prieto, J. (Jesús); Colombo, M.P. (Mario P.); Chen, L. (Lieping); Melero, I. (Ignacio)
2009Lysine 63 polyubiquitination in immunotherapy and in cancer-promoting inflammationArticuloMartinez-Forero, I. (Iván); Rouzaut, A. (Ana); Palazon, A. (Asís); Dubrot, J. (Juan); Melero, I. (Ignacio)
2004MAGE antigens: therapeutic targets in hepatocellular carcinoma?ArticuloSarobe, P. (Pablo); Feijoo, E. (Esperanza); Alfaro, C. (Carlos); Mazzolini, G. (Guillermo); Melero, I. (Ignacio)
2015Molecular and cellular basis for immunomodulation with monoclonal antibodiesArticuloMelero, I. (Ignacio)
2012Molecular pathways: hypoxia response in immune cells fighting or promoting cancerArticuloPalazon, A. (Asís); Aragones, J. (Julián); Morales-Kastresana, A. (Aizea); Ortiz-de-Landazuri, M. (Manuel); Melero, I. (Ignacio)
2021Mouse Models of Peritoneal Carcinomatosis to Develop Clinical ApplicationsRevisionBella-Carreño, Á. (Ángela); Di-Trani, C.A. (Claudia Augusta); Fernández-Sendín, M. (Myriam); Arrizabalaga, L. (Leire); Cirella, A. (Assunta); Teijeira, A. (Álvaro); Medina-Echeverz, J. (José); Melero, I. (Ignacio); Berraondo, P. (Pedro); Aranda, F. (Fernando)
2023mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapyArticuloOlivera, I. (Irene); Bolaños, E. (Elixabet); González-Gomariz, J. (José); Hervas-Stubbs, S. (Sandra); Mariño, K. (Karina); Luri-Rey, C. (Carlos); Etxeberria, I. (Iñaki); Cirella, A. (Assunta); Egea, J. (Josune); González-Vaz, J. (Javier); Garasa, S. (Saray); Álvarez-Rodríguez, M. (Maite); Eguren-Santamaría, I. (Iñaki); Guedan, S. (Sonia); Fernandez-Sanmamed, M. (Miguel); Berraondo, P. (Pedro); Rabinovich, G.A. (Gabriel A.); Teijeira, A. (Álvaro); Melero, I. (Ignacio)
2008Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapiesArticuloMelero, I. (Ignacio); Murillo, O. (Oihana); Dubrot, J. (Juan); Hervas-Stubbs, S. (Sandra); Perez-Gracia, J.L. (Jose Luis)
2018Neoadjuvant immunotherapy in non-small cell lung cancer: the sooner the better?ArticuloPerez-Gracia, J.L. (Jose Luis); Fernandez-Sanmamed, M. (Miguel); Melero, I. (Ignacio)
2019Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastomaArticuloSchalper, K.A. (Kurt A.); Rodriguez-Ruiz, M.E. (María Esperanza); Diez-Valle, R. (Ricardo); López-Janeiro, Á. (Álvaro); Porciuncula, A. (Angelo); Idoate, M.A. (Miguel Ángel); Inoges, S. (Susana); Andrea, C.E. (Carlos Eduardo) de; Lopez-Diaz-de-Cerio, A. (Ascensión); Tejada-Solis, S. (Sonia); Berraondo, P. (Pedro); Villarroel-Espindola, F. (Franz); Choi, J. (Jungmin); Gurpide, A. (Alfonso); Giraldez, M. (Miriam); Goicoechea, I. (Iosune); Gallego-Perez-Larraya, J. (Jaime); Fernandez-Sanmamed, M. (Miguel); Perez-Gracia, J.L. (Jose Luis); Melero, I. (Ignacio)
2019New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axisRevisionEtxeberria, I. (Iñaki); González-Vaz, J. (Javier); Teijeira, A. (Álvaro); Melero, I. (Ignacio)
2007New treatments for renal carcinomaArticuloPerez-Gracia, J.L. (Jose Luis); Lopez-Picazo, J.M. (José M.); Olier, C. (Clara); Alfaro, C. (Carlos); Garcia-Foncillas, J. (Jesús); Melero, I. (Ignacio); Gurpide, A. (Alfonso)
2015Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient miceArticuloFernandez-Sanmamed, M. (Miguel); Rodriguez, I. (Inmaculada); Schalper, K.A. (Kurt A.); Oñate, C. (Carmen); Azpilikueta, A. (Arantza); Rodriguez-Ruiz, M.E. (María Esperanza); Morales-Kastresana, A. (Aizea); Labiano, S. (Sara); Perez-Gracia, J.L. (Jose Luis); Martin-Algarra, S. (Salvador); Alfaro, C. (Carlos); Mazzolini, G. (Guillermo); Sarno, F. (Francesca); Hidalgo, M. (Manuel); Korman, A.J. (Alan J.); Jure-Kunkel, M. (María); Melero, I. (Ignacio)
2023Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040ArticuloEl-Khoueiry, A. (Anthony); Trojan, J. (Jörg); Meyer, T. (Tim); Yau, T. (Thomas); Melero, I. (Ignacio); Kudo, M. (Masatoshi); Hsu, C. (Chiun); Kim, T.Y. (Tae-You); Choo, S.P. (Su-Pin); Kang, Y.K. (Yoon-Koo); Yeo, W. (W.); Chopra, A. (A.); Soleymani, S. (S.); Yao, J. (J.); Neely, J. (Jaclyn); Tschaika, M. (Marina); Welling, T.H. (T. H.); Sangro, B. (Bruno)
2022Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialArticuloYau, T. (Thomas); Park, J.W. (Joong-Won); Finn, R.S. (Richard S.); Cheng, A.L. (Ann-Lii); Mathurin, P. (Philippe); Edeline, J. (Julien); Kudo, M. (Masatoshi); Harding, J.J. (James J.); Merle, P. (Philippe); Rosmorduc, O. (Olivier); Wyrwicz, L. (Lucjan); Schott, E. (Eckart); Choo, S.P. (Su-Pin); Kate-Kelley, R. (Robin); Sieghart, W. (Wolfgang); Assenat, E. (Eric); Zaucha, R. (Renata); Furuse, J. (Junji); Abou-Alfa, G.K. (Ghassan K.); El-Khoueiry, A. (Anthony); Melero, I. (Ignacio); Begic, D. (Damir); Chen, G. (Gong); Neely, J. (Jaclyn); Wisniewski, T. (Tami); Tschaika, M. (Marina); Sangro, B. (Bruno)
30-Jan-2020On mechanisms underlying efficacy and safety in cancer immunotherapyTesisCordeiro-Minute, L. R (Luna Ridan)
15-Jul-2019On the hipoxia regulation of CD137 and CD69 expressionTesisLabiano, S. (Sara)
2009Palettes of vaccines and immunostimulatory monoclonal antibodies for combinationArticuloMelero, I. (Ignacio); Martinez-Forero, I. (Iván); Dubrot, J. (Juan); Suarez, N. (Natalia); Palazon, A. (Asís); Chen, L. (Lieping)
2003Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosisArticuloMazzolini, G. (Guillermo); Narvaiza, I. (Íñigo); Martinez-Cruz, L.A. (L. Alfonso); Arina, A. (Ainhoa); Barajas, M. (Miguel); Galofre, J.C. (Juan Carlos); Qian, C. (Cheng); Mato, J.M. (José María); Prieto, J. (Jesús); Melero, I. (Ignacio)
2004Pasado, presente y futuro de la vacunación anti-idiotipoArticuloRodriguez-Calvillo, M. (Mercedes); Inoges, S. (Susana); Lopez-Diaz-de-Cerio, A. (Ascensión); Zabalegui, N. (Natalia); Panizo, C. (Carlos); Hernandez, M. (Milagros); Perez-Calvo, J. (Javier); Prosper-Cardoso, F. (Felipe); Melero, I. (Ignacio); Sanchez-Ibarrola, A. (Alfonso); Rocha, E. (Eduardo); Bendandi, M. (Maurizio)